Literature DB >> 24275548

The dimensional structure of posttraumatic stress symptomatology in 323,903 U.S. veterans.

Ilan Harpaz-Rotem1, Jack Tsai2, Robert H Pietrzak3, Rani Hoff4.   

Abstract

There is ongoing debate regarding the optimal dimensional structure of posttraumatic stress disorder symptomatology. A better understanding of this structure has significant implications, as it can provide more refined phenotypic measures for use in studies of the etiology and neurobiology of PTSD, as well as for use as endpoints in treatment studies of this disorder. In this study we analyzed the dimensional structure of PTSD symptomatology, as assessed using the PTSD Symptom Checklist-Military Version in 323,903 Veterans. Confirmatory factor analyses were used to compare two 4-factor models and a newly proposed 5-factor model to the 3-factor DSM-IV model of PTSD symptom dimensionality. To evaluate the external validity of the best-fitting model, we then conducted a structural equation model examining how the symptom dimensions of this model related to diagnoses of depression, anxiety, and substance use disorder. Results indicated that a newly proposed 5-factor 'dysphoric arousal' model comprised of separate re-experiencing, avoidance, numbing, dysphoric arousal, and anxious arousal symptom clusters provided a significantly better fit to the data compared to the DSM-IV and the two alternative four-factor models. External validity analyses revealed that numbing symptoms were most strongly related to diagnoses of depression and substance use disorder, and that dysphoric arousal symptoms were most strongly related to a diagnosis of anxiety disorder. Thus the dimensional structure of PTSD may be best represented by five symptom dimensions. The clinical implications of these results and implications for further refinement of extant PTSD assessment instruments are discussed. Published by Elsevier Ltd.

Entities:  

Keywords:  Anxiety; Depression; PTSD; Psychopathology; Substance use disorder

Mesh:

Year:  2013        PMID: 24275548     DOI: 10.1016/j.jpsychires.2013.10.020

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  18 in total

Review 1.  Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder.

Authors:  Alexander Neumeister; Jordan Seidel; Benjamin J Ragen; Robert H Pietrzak
Journal:  Psychoneuroendocrinology       Date:  2014-10-22       Impact factor: 4.905

2.  PTSD's Underlying Dimensions in Typhoon Haiyan Survivors: Assessing DSM-5 Symptomatology-Based PTSD Models and Their Relation to Posttraumatic Cognition.

Authors:  Imelu G Mordeno; Jennifer Gay E Carpio; Ma Jenina N Nalipay; Rhea Lina J Saavedra
Journal:  Psychiatr Q       Date:  2017-03

3.  Posttraumatic Stress Disorder Symptom Association With Subsequent Risky and Problem Drinking Initiation.

Authors:  Kara M Bensley; Amber D Seelig; Richard F Armenta; Anna C Rivera; Arthur V Peterson; Isabel G Jacobson; Alyson J Littman; Charles Maynard; Jonathan B Bricker; Edward J Boyko; Rudolph P Rull; Emily C Williams
Journal:  J Addict Med       Date:  2018 Sep/Oct       Impact factor: 3.702

Review 4.  Post-traumatic stress disorder and cardiometabolic disease: improving causal inference to inform practice.

Authors:  K C Koenen; J A Sumner; P Gilsanz; M M Glymour; A Ratanatharathorn; E B Rimm; A L Roberts; A Winning; L D Kubzansky
Journal:  Psychol Med       Date:  2016-10-04       Impact factor: 7.723

5.  DSM-5 Posttraumatic Stress Disorder Symptom Structure in Disaster-Exposed Adolescents: Stability across Gender and Relation to Behavioral Problems.

Authors:  Xing Cao; Li Wang; Chengqi Cao; Jianxin Zhang; Jon D Elhai
Journal:  J Abnorm Child Psychol       Date:  2017-05

6.  Incidence and Risk Factors for Intensive Care Unit-related Post-traumatic Stress Disorder in Veterans and Civilians.

Authors:  Mayur B Patel; James C Jackson; Alessandro Morandi; Timothy D Girard; Christopher G Hughes; Jennifer L Thompson; Amy L Kiehl; Mark R Elstad; Mitzi L Wasserstein; Richard B Goodman; Jean C Beckham; Rameela Chandrasekhar; Robert S Dittus; E Wesley Ely; Pratik P Pandharipande
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

7.  Elucidating dimensions of posttraumatic stress symptoms and their functional correlates in disaster-exposed adolescents.

Authors:  Jennifer A Sumner; Robert H Pietrzak; Carla Kmett Danielson; Zachary W Adams; Kenneth J Ruggiero
Journal:  J Psychiatr Res       Date:  2014-09-16       Impact factor: 4.791

8.  Dimensional structure and correlates of posttraumatic stress symptoms following suspected acute coronary syndrome.

Authors:  Jennifer A Sumner; Ian M Kronish; Robert H Pietrzak; Daichi Shimbo; Jonathan A Shaffer; Faith E Parsons; Donald Edmondson
Journal:  J Affect Disord       Date:  2015-07-29       Impact factor: 4.839

9.  POSTTRAUMATIC STRESS SYMPTOMS AND AVERSION TO AMBIGUOUS LOSSES IN COMBAT VETERANS.

Authors:  Lital Ruderman; Daniel B Ehrlich; Alicia Roy; Robert H Pietrzak; Ilan Harpaz-Rotem; Ifat Levy
Journal:  Depress Anxiety       Date:  2016-03-21       Impact factor: 6.505

10.  Cannabinoid Receptor 1 rs1049353 Variant, Childhood Abuse, and the Heterogeneity of PTSD Symptoms: Results From the National Health and Resilience in Veterans Study.

Authors:  Nachshon Korem; Or Duek; Ke Xu; Ilan Harpaz-Rotem; Robert H Pietrzak
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.